INmune Bio Inc (INMB)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 62.48M
P/E Ratio
0.00
Revenue (TTM)
$ 50K
Volume
0
52W High
$ 10.50
52W Low
$ 1.89
Dividend Yield
0.00%
Beta
0.98
Technicals
50-Day MA
3.5767
200-Day MA
6.1734
52 Week High
10.5
52 Week Low
1.89
About INMB
INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.
Employees
13
Headquarters
Boca Raton, FL
CEO
Dr. Raymond Joseph Tesi M.D.
Latest News
Identifying reversal signals in INMB - Exit Point & Weekly High Return Opportunities - Newser
13 hours ago • Google News